About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
| Publication Type | Academic Article |
| Authors | Crystal R, Mastrangeli A, Sanders A, Cooke J, King T, Gilbert F, Henschke C, Pascal W, Herena J, Harvey B |
| Journal | Hum Gene Ther |
| Volume | 6 |
| Issue | 5 |
| Pagination | 667-703 |
| Date Published | 05/01/1995 |
| ISSN | 1043-0342 |
| Keywords | Adenoviridae, Clinical Trials as Topic, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Genetic Therapy |
| DOI | 10.1089/hum.1995.6.5-667 |
| PubMed ID | 7578402 |